Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thalamic 5-HT<sub>2A</sub> receptor activation reduces GABA uptake, increases tonic GABA<sub>A</sub> inhibition and induces absence seizures in Wistar rats.

Neuropharmacology·2026
Same author

Developmental and cell type-specific contributions of thalamic serotonin 2A receptors to absence seizures.

Epilepsia·2026
Same author

Heterogeneity of ictal firing during generalized seizures in the awake cortex.

Cerebral cortex (New York, N.Y. : 1991)·2026
Same author

Thalamic distribution and effects of 5-HT2C receptors on tonic GABAA inhibition and absence seizures: implications for treatment.

Frontiers in pharmacology·2026
Same author

BDNF prevents amyloid-β-induced exacerbation of mGluR5-driven Ca<sup>2+</sup> transients in astrocytes through TrkB-Tc activation.

Cell calcium·2026
Same author

Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses.

International journal of molecular sciences·2025
Same journal

Loss of Function of AFG3L2 Leading to Developmental and Epileptic Encephalopathy.

CNS neuroscience & therapeutics·2026
Same journal

Icariin Alleviates Diabetes-Associated Cognitive Dysfunction Through Modulation of LCN2-MEK/ERK Signaling-Associated Neuroinflammation.

CNS neuroscience & therapeutics·2026
Same journal

Potential Mechanisms of Trimetazidine and Coenzyme Q10 Against Antipsychotic-Induced Myocarditis: A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Study.

CNS neuroscience & therapeutics·2026
Same journal

Sympathetic Overactivation Drives Neurogenic Alveolar Epithelial Pyroptosis via the PIEZO2-ER Stress Pathway in Acute Lung Injury Following Intracerebral Hemorrhage.

CNS neuroscience & therapeutics·2026
Same journal

Roles of Microglia in Cerebral Small Vessel Disease.

CNS neuroscience & therapeutics·2026
Same journal

Mapping the Disrupted Connectome in Spinocerebellar Ataxia Type 3: A Network-Based Statistics Study Identifying Novel Therapeutic Targets for Neuromodulation.

CNS neuroscience & therapeutics·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K

Circuit-Selective FAAH Inhibition Suppresses Experimental Absence Seizures.

Tatiana P Morais1,2, Cristiano Bombardi3, Vincenzo Crunelli1,4

  • 1Neuroscience Division, School of Biosciences, Cardiff University, Cardiff, UK.

CNS Neuroscience & Therapeutics
|April 13, 2026
PubMed
Summary
This summary is machine-generated.

Inhibiting fatty acid amide hydrolase (FAAH) effectively reduces absence seizures in rats by boosting anandamide (AEA) levels. This approach targets thalamocortical networks, offering a novel therapeutic strategy for childhood absence epilepsy (CAE).

Keywords:
CB1 receptorFAAH inhibitionGAERSPF‐04457845absence epilepsyendocannabinoidsin vivo electrophysiologyspike–wave dischargesthalamocortical networkventrobasal thalamus

More Related Videos

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
09:39

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation

Published on: June 7, 2016

11.2K
Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
09:39

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation

Published on: June 7, 2016

11.2K
Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.5K

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Pharmacology

Background:

  • Childhood absence epilepsy (CAE) involves corticothalamic network dysfunction leading to spike-wave discharges (SWDs) and seizures.
  • Existing treatments for CAE are often ineffective, leaving a significant portion of patients pharmacoresistant and prone to neuropsychiatric issues.
  • The endocannabinoid system (ECS) regulates network stability, but its role in absence epilepsy treatment is not fully understood.

Purpose of the Study:

  • To investigate if inhibiting fatty acid amide hydrolase (FAAH) to increase endogenous cannabinoid levels, specifically anandamide (AEA), can suppress absence seizures.
  • To determine the contribution of thalamic mechanisms in mediating the anti-seizure effects of FAAH inhibition.
  • To explore the therapeutic potential of FAAH inhibitors for CAE.

Main Methods:

  • Video-EEG recordings were used in Genetic Absence Epilepsy Rats from Strasbourg (GAERS) to monitor spike-wave discharges (SWDs).
  • The irreversible FAAH inhibitor PF-04457845 was administered systemically (acutely and subchronically) and directly into the ventrobasal (VB) thalamus.
  • Seizure metrics including number, total time, and duration were quantified to assess treatment efficacy.

Main Results:

  • FAAH inhibition significantly reduced absence seizures by decreasing seizure number and cumulative seizure time, without affecting seizure duration.
  • These anti-seizure effects were sustained with repeated administration, indicating no development of tolerance.
  • Microinfusion of the FAAH inhibitor into the VB thalamus replicated the seizure-suppressing effects, confirming the thalamus as a key site of action and suggesting increased AEA and CB1 receptor signaling.

Conclusions:

  • Selective enhancement of endogenous cannabinoid signaling via FAAH inhibition effectively suppresses absence-like activity by modulating thalamocortical network dynamics.
  • Unlike direct CB1 agonists, FAAH inhibition offers circuit-selective modulation, preserving specificity and avoiding exacerbation of seizures.
  • The ventrobasal (VB) thalamus is identified as a critical brain region for ECS-mediated seizure control, supporting FAAH inhibitors as a promising therapeutic strategy for CAE.